Valuation
- Market cap
- 10,132,000
- Revenue TTM
- $0
- Net income TTM
- $-37,880,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 1,069,300
- Avg volume
- 2,282,298
- Day's range
- $0.15 – $0.17
- Shares out
- 64,532,000
- Stochastic %K
- 8%
- Beta
- 1.62
- Analysts
- Strong Buy
- Price target
- $1.00
Company profile
GlycoMimetics, Inc. engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, Maryland.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 240 243 1201
- Website
- https://www.glycomimetics.com
- Address
- P.O. Box 65, Monrovia, United States
Latest news
No headlines yet.
